Publication date: Dec 01, 2024
Parsonage-Turner syndrome (PTS) is a rare brachial plexus neuropathy with a sudden onset of upper extremity pain, weakness, and loss of range of motion (ROM). Studies on occupational therapy (OT) interventions are limited. The aim of this case report was to explore the OT experiences, interventions, and outcomes of a patient with PTS. The patient was a 44-year-old woman with COVID-19 who was admitted to the intensive care unit (ICU). She was intubated and placed in the prone position for 16 hours a day. The diagnosis of PTS was confirmed. Data included the OT medical record and interviews with the patient and the treating occupational therapist. The OT intervention type and frequency are reported. Outcome measurements showed 80-100% improvement for the affected left upper extremity (LUE). Manual muscle testing scores returned to WNL except for shoulder internal and external rotation, with improved but limited grip, pinch, and fine motor coordination. The qualitative data emphasized the importance of considering the sociocultural perspective and psychosocial effects of PTS with OT interventions. This study reported the OT interventions and outcomes of this rare condition. All outcome measures demonstrated improvement, many within normal limits. Considering the sociocultural and psychosocial effects of the patient appeared to contribute to improved outcomes.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Covid | brachial plexus neuritis |
| Hours | hemiplegia |
| Pain | neuralgic amyotrophy |
| Therapist | occupational therapy |
| shoulder pain |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Parsonage-Turner Syndrome |
| disease | MESH | brachial plexus neuropathy |
| disease | MESH | COVID-19 |
| disease | IDO | intervention |
| pathway | REACTOME | Reproduction |
| disease | MESH | hemiplegia |
| disease | MESH | atrophy |
| disease | MESH | radiculitis |
| disease | MESH | Neuropathic pain |
| disease | MESH | etiology |
| disease | MESH | abnormalities |
| disease | MESH | infection |
| disease | MESH | paresis |
| disease | MESH | edema |
| disease | MESH | sweating |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | IDO | history |
| disease | MESH | thyroiditis |
| disease | MESH | bursitis |
| drug | DRUGBANK | Gabapentin |
| disease | IDO | facility |
| pathway | REACTOME | Release |
| disease | IDO | process |
| drug | DRUGBANK | Polyethylene glycol |
| disease | MESH | scarring |
| disease | MESH | weight loss |
| disease | MESH | brain fog |
| disease | MESH | lifestyle |
| disease | MESH | Musculoskeletal pain |
| disease | MESH | Lyme disease |
| disease | MESH | muscular atrophy |
| disease | MESH | syndrome |
| disease | MESH | Minimal clinically important difference |
| drug | DRUGBANK | Cyclic Adenosine Monophosphate |
| disease | MESH | spinal stenosis |